Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00596
|
|||||
Drug Name |
Methyldopa
|
|||||
Synonyms |
(-)-3-(3,4-Dihydroxyphenyl)-2-Methyl-L-Alanine Sesqui-Hydrate; (2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid; (S)-(-)-alpha-Methyldopa; 3-(3,4-DIHYDROXYPHENYL)-2-METHYL-L-ALANINE; 3-Hydroxy-.alpha.-methyl-L-tyrosine; 3-Hydroxy-alpha-methyl-L-tyrosine; AMD; Aldomet; Aldomet (TN); Aldometil; Aldomin; Aldoril (TN); Aldoril D30; Aldoril D50; Aldoril, Dopamet, Dopegyt, Methyldopa; Alpha medopa; Alpha-Methyl dopa; Alpha-Methyl-L-3,4-dihydroxyphenylalanine; Alpha-Methyl-beta-(3,4-dihydroxyphenyl)-L-alanine; Alpha-Methyldihydroxyphenylalanine; Alpha-Methyldopa; Alpha-Methyldopa (VAN); Alphamethyldopa; Apo-Methyldopa; Bayer 1440 L; Baypresol; Becanta; Dopamet; Dopamet (TN); Dopamethyperpax; Dopatec; Dopegit; Dopegyt; Dopegyt (TN); Dopergit; Grospisk; Hyperpax; Hypolag; L(-)-beta-(3,4-Dihydroxyphenyl)-alpha-methylalanine; L-(-)-3-(3,4-Dihydroxyphenyl)-2-methylalanine; L-(-)-alpha-Methyl-beta-(3,4-dihydroxyphenyl)alanine; L-(alpha-Md); L-2-Amino-2-methyl-3-(3,4-dihydroxyphenyl)propionic acid; L-3-(3,4-Dihydroxyphenyl)-2-methylalanine; L-Methyl Dopa; L-Methyldopa; L-alpha-Methyl DOPA; L-alpha-Methyl-3,4-dihydroxyphenylalanine; L-alpha-Methyldopa; LT00847269; Levo-3-(3,4-Dihydroxyphenyl)-2-methylalanine; METHYL DOPA (SEE ALSO METHYL DOPA SESQUIHYDRATE); MK 351; MK-351; Medomet; Medopa; Medopal; Medopren; Methoplain; Methyl dopa; Methyl-L-dopa; Methyldopa (INN); Methyldopa (L,-); Methyldopa (anhydrous); Methyldopa anhydrous; Methyldopum; Methyldopum [INN-Latin]; Metildopa; Metildopa [INN-Spanish]; Mk. b51; Novomedopa; Nr.C 2294; Nu-Medopa; Presinol; Presolisin; Sedometil; Sembrina
|
|||||
Drug Type |
Small molecular drug
|
|||||
Therapeutic Class |
Antihypertensive Agents
|
|||||
Structure |
|
![]() |
||||
3D MOL | 2D MOL | |||||
Formula |
C10H13NO4
|
|||||
Canonical SMILES |
CC(CC1=CC(=C(C=C1)O)O)(C(=O)O)N
|
|||||
InChI |
InChI=1S/C10H13NO4/c1-10(11,9(14)15)5-6-2-3-7(12)8(13)4-6/h2-4,12-13H,5,11H2,1H3,(H,14,15)/t10-/m0/s1
|
|||||
InChIKey |
CJCSPKMFHVPWAR-JTQLQIEISA-N
|
|||||
CAS Number |
CAS 555-30-6
|
|||||
Pharmaceutical Properties | Molecular Weight | 211.21 | Topological Polar Surface Area | 104 | ||
Heavy Atom Count | 15 | Rotatable Bond Count | 3 | |||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 5 | |||
XLogP |
-1.9
|
|||||
PubChem CID | ||||||
PubChem SID |
10321684
,11113581
,11335317
,11360556
,11363831
,11366393
,11368955
,11371621
,11373686
,11377117
,11461528
,11466354
,11467474
,11484792
,11485988
,11488884
,11490317
,11491869
,11494751
,14748911
,17405414
,26611818
,26679555
,34704829
,46508535
,47290999
,47440113
,47736324
,47736325
,47810607
,48034965
,48110315
,48184859
,48416254
,48423673
,49698436
,49854436
,50104474
,50104475
,50104476
,50104477
,50970645
,53777959
,53790662
,597355
,7979942
,8139902
,8149423
,8175761
,9403
|
|||||
TTD Drug ID |
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.